Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Timber Pharmaceuticals, Inc. | a2230320zex-5_1.htm |
| EX-4.18 - EX-4.18 - Timber Pharmaceuticals, Inc. | a2230320zex-4_18.htm |
| EX-4.17 - EX-4.17 - Timber Pharmaceuticals, Inc. | a2230320zex-4_17.htm |
| EX-4.16 - EX-4.16 - Timber Pharmaceuticals, Inc. | a2230320zex-4_16.htm |
| EX-3.3 - EX-3.3 - Timber Pharmaceuticals, Inc. | a2230320zex-3_3.htm |
| EX-1.1 - EX-1.1 - Timber Pharmaceuticals, Inc. | a2230320zex-1_1.htm |
| S-1/A - S-1/A - Timber Pharmaceuticals, Inc. | a2230320zs-1a.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Amendment No. 2 to Registration Statement on Form S-1 of our report (which contains an explanatory paragraph relating to the Company's ability to continue as a going concern as described in Note 2 to the consolidated financial statements) dated May 2, 2016, relating to the consolidated financial statements of BioPharmX Corporation, which appears in the Annual Report on Form 10-K of BioPharmX Corporation for the year ended January 31, 2016. We also consent to the reference of our firm under the heading "Experts" in such Registration Statement.
/s/ Burr Pilger Mayer, Inc.
San Jose, California
November 18, 2016
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM